Drug name - Sotylize

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10206895 ARBOR PHARMS LLC Sotalol compositions and uses of the same Apr, 2034

(11 years from now)

US11013703 ARBOR PHARMS LLC Sotalol compositions and uses of the same Apr, 2034

(11 years from now)

US9724297 ARBOR PHARMS LLC Sotalol compositions and uses of the same Aug, 2035

(12 years from now)

Drugs and Companies using SOTALOL HYDROCHLORIDE ingredient

Treatment: Sotylize is indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (afib/afl)] in patients with symptomatic afib/afl who are currently in sinus rhythm; indicated for the treatment of ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgement of the physician are life-threatening; Sotylize is indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (afib/afl)] in patients with symptomatic afib/afl who are currently in sinus rhythm

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
5MG/ML (5MG/ML) SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.